Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
15.64
-1.08 (-6.46%)
At close: Nov 20, 2025, 4:00 PM EST
15.68
+0.04 (0.26%)
Pre-market: Nov 21, 2025, 7:00 AM EST
TNXP Employees
Tonix Pharmaceuticals Holding had 81 employees as of December 31, 2024. The number of employees decreased by 22 or -21.36% compared to the previous year.
Employees
81
Change (1Y)
-22
Growth (1Y)
-21.36%
Revenue / Employee
$127,148
Profits / Employee
-$1,224,926
Market Cap
184.19M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81 | -22 | -21.36% |
| Dec 31, 2023 | 103 | -14 | -11.97% |
| Dec 31, 2022 | 117 | 44 | 60.27% |
| Dec 31, 2021 | 73 | 47 | 180.77% |
| Dec 31, 2020 | 26 | 10 | 62.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TNXP News
- 4 days ago - Tonix Pharmaceuticals Announces U.S. Commercial Availability of TONMYA™ (cyclobenzaprine HCl sublingual tablets) as a First-in-Class Fibromyalgia Treatment - GlobeNewsWire
- 6 days ago - Tonix Q3 2025 Earnings Recap And Tonmya Launch Outlook - Seeking Alpha
- 10 days ago - Tonix Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 15 days ago - Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference - GlobeNewsWire
- 17 days ago - Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection - GlobeNewsWire
- 24 days ago - Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025 - GlobeNewsWire
- 25 days ago - Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence - GlobeNewsWire
- 4 weeks ago - Tonix Pharmaceuticals Announces First Patient Dosed in the Investigator-Initiated FOCUS Study of Tonix's Intranasal Potentiated Oxytocin in AVP-D Conducted by Massachusetts General Hospital - GlobeNewsWire